Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Best Pract Res Clin Gastroenterol. 2015 May 9;29(3):503–521. doi: 10.1016/j.bpg.2015.04.005

Fig. 2.

Fig. 2

Non-HLA susceptibility regions shared between celiac disease and select immune-modulated diseases [144,145]. A genome-wide significance threshold was set at P = 5 × 10−8. FUT2 was included despite not being identified in a celiac disease-specific GWAS.